Academic Lead: Prof. Francesc Artigas, Consejo Superior de Investigaciones Cientifícas, Spain
EFPIA Lead: Prof. Michael Spedding, Institut de Recherches Servier, France
The revolution in neurosciences means that industry and academia are working on very similar precompetitive technologies independently and the very act of sharing these technologies, standardising, exchanging difficulties and reference compounds makes for an immense economy of effort and resources. The IMI provides an opportunity for the EFPIA partners to integrate their unique strengths (background pharmacokinetic analysis, unpublished knowledge and perspectives, molecular pharmacology resources) to be coupled to key academic questions; furthermore where these questions relate to drug effects – partnering with EFPIA ensures that there is explicit attention to PK issues so that the trivial (but underestimated) problems of drug disposition do not confound the interpretation of data. On the other hand the academic groups will bring to this collaboration unique expertise (single cell and local potentials) that is not presently available in its entirety within any single EFPIA lab. Thus, the collaboration will lead to new science and new capacity amongst partners.